olprinone has been researched along with Muscle Contraction in 8 studies
olprinone: RN refers to HCl; structure given in first source
Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We also demonstrated that intraperitoneal administration of olprinone improves diaphragmatic fatigability and inhibits an increase in myeloperoxidase activity induced by abdominal sepsis." | 7.72 | Olprinone improves diaphragmatic contractility and fatigability during abdominal sepsis in a rat model. ( Hagiwara, S; Iwasaka, H; Kira, S; Kitano, T; Miyakawa, H; Noguchi, T; Oishi, K, 2004) |
| " We also demonstrated that intraperitoneal administration of olprinone improves diaphragmatic fatigability and inhibits an increase in myeloperoxidase activity induced by abdominal sepsis." | 3.72 | Olprinone improves diaphragmatic contractility and fatigability during abdominal sepsis in a rat model. ( Hagiwara, S; Iwasaka, H; Kira, S; Kitano, T; Miyakawa, H; Noguchi, T; Oishi, K, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uemura, A | 2 |
| Fujii, Y | 4 |
| Toyooka, H | 4 |
| Suzuki, S | 1 |
| Sawada, K | 1 |
| Adachi, H | 1 |
| Miyakawa, H | 1 |
| Oishi, K | 1 |
| Hagiwara, S | 1 |
| Kira, S | 1 |
| Kitano, T | 1 |
| Iwasaka, H | 1 |
| Noguchi, T | 1 |
| Holubarsch, C | 1 |
| Hasenfuss, G | 1 |
| Just, H | 1 |
| Alpert, NR | 1 |
| Fujimoto, S | 1 |
| Ohashi, M | 1 |
| Hiramoto, A | 1 |
| Inoue, Y | 1 |
| Nagai, K | 1 |
| Shiokawa, H | 1 |
| Itoh, T | 1 |
| Takahashi, S | 1 |
| Tajimi, M | 1 |
| Ozaki, H | 1 |
| Sato, K | 1 |
| Karaki, H | 1 |
8 other studies available for olprinone and Muscle Contraction
| Article | Year |
|---|---|
Olprinone for the treatment, but not prevention, of fatigue-induced changes in guinea-pig diaphragmatic contractility.
Topics: Animals; Cardiotonic Agents; Diaphragm; Guinea Pigs; Imidazoles; In Vitro Techniques; Male; Muscle C | 2003 |
Olprinone improves diaphragmatic contractility and fatigability during abdominal sepsis in a rat model.
Topics: Abdomen; Analysis of Variance; Animals; Cardiotonic Agents; Cecum; Diaphragm; Disease Models, Animal | 2004 |
Positive inotropism and myocardial energetics: influence of beta receptor agonist stimulation, phosphodiesterase inhibition, and ouabain.
Topics: Adrenergic beta-Agonists; Animals; Deoxyepinephrine; Guinea Pigs; Hot Temperature; Imidazoles; In Vi | 1994 |
Vasorelaxant effect of olprinone, an inhibitor of phosphodiesterase 3, on mesenteric small artery and vein of rabbits.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Caffeine; Calcium; Colforsin; Cyclic Nucleotide Phosph | 1998 |
The effect of olprinone compared with milrinone on diaphragmatic muscle function in dogs.
Topics: Animals; Blood Pressure; Cardiac Output; Diaphragm; Dogs; Heart Rate; Imidazoles; Milrinone; Muscle | 1999 |
Different effects of olprinone on contractility in nonfatigued and fatigued diaphragm in dogs.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Calcium Channel Blockers; Cyclic Nucleotide Phosphodie | 2000 |
Inhaled olprinone improves contractility of fatigued canine diaphragm.
Topics: Administration, Inhalation; Animals; Diaphragm; Dogs; Dose-Response Relationship, Drug; Electric Sti | 2002 |
Effect of a novel inhibitor of cyclic AMP phosphodiesterase, E-1020, on cytosolic Ca++ level and contraction in vascular smooth muscle.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Aorta, Thoracic; Calcium; Cardiotonic Agents; Cytosol; | 1991 |